Exact Mass: 334.0929

Exact Mass Matches: 334.0929

Found 132 metabolites which its exact mass value is equals to given mass value 334.0929, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Penicillin G

(2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C16H18N2O4S (334.0987)


Penicillin G is narrow spectrum antibiotic used to treat infections caused by susceptible bacteria. It is a natural penicillin antibiotic that is administered intravenously or intramuscularly due to poor oral absorption. Penicillin G may also be used in some cases as prophylaxis against susceptible organisms. Natural penicillins are considered the drugs of choice for several infections caused by susceptible gram positive aerobic organisms, such as Streptococcus pneumoniae, groups A, B, C and G streptococci, nonenterococcal group D streptococci, viridans group streptococci, and non-penicillinase producing staphylococcus. Aminoglycosides may be added for synergy against group B streptococcus (S. agalactiae), S. viridans, and Enterococcus faecalis. The natural penicillins may also be used as first or second line agents against susceptible gram positive aerobic bacilli such as Bacillus anthracis, Corynebacterium diphtheriae, and Erysipelothrix rhusiopathiae. Natural penicillins have limited activity against gram negative organisms; however, they may be used in some cases to treat infections caused by Neisseria meningitidis and Pasteurella. They are not generally used to treat anaerobic infections. Resistance patterns, susceptibility and treatment guidelines vary across regions. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CE - Beta-lactamase sensitive penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Chlorpromazine-N-oxide

3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropanamine oxide

C17H19ClN2OS (334.0907)


Chlorpromazine-N-oxide is a metabolite of chlorpromazine. Chlorpromazine (as chlorpromazine hydrochloride, abbreviated CPZ; marketed in the United States as Thorazine and elsewhere as Largactil) is a typical antipsychotic. First synthesized on December 11, 1950, chlorpromazine was the first drug developed with specific antipsychotic action, and would serve as the prototype for the phenothiazine class of drugs, which later grew to comprise several other agents. (Wikipedia)

   
   

19-Hydroxy-8-O-methyltetrangulol

19-Hydroxy-8-O-methyltetrangulol

C20H14O5 (334.0841)


   

Triphenyltetrazolium chloride

2,3,5-Triphenyltetrazolium chloride

C19H15N4. Cl (334.0985)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D013778 - Tetrazolium Salts D004396 - Coloring Agents

   

(S)-a-Amino-2,5-dihydro-5-oxo-4-isoxazolepropanoic acid N2-glucoside

2-amino-3-{5-oxo-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,5-dihydro-1,2-oxazol-4-yl}propanoic acid

C12H18N2O9 (334.1012)


(S)-a-Amino-2,5-dihydro-5-oxo-4-isoxazolepropanoic acid N2-glucoside is found in pulses. (S)-a-Amino-2,5-dihydro-5-oxo-4-isoxazolepropanoic acid N2-glucoside is isolated from Pisum sativum (peas Isolated from Pisum sativum (peas). (S)-a-Amino-2,5-dihydro-5-oxo-4-isoxazolepropanoic acid N2-glucoside is found in pulses and common pea.

   

hydroxychlorpromazine

8-chloro-10-[3-(dimethylamino)propyl]-10H-phenothiazin-3-ol

C17H19ClN2OS (334.0907)


hydroxychlorpromazine is a metabolite of chlorpromazine. Chlorpromazine (as chlorpromazine hydrochloride, abbreviated CPZ; marketed in the United States as Thorazine and elsewhere as Largactil) is a typical antipsychotic. First synthesized on December 11, 1950, chlorpromazine was the first drug developed with specific antipsychotic action, and would serve as the prototype for the phenothiazine class of drugs, which later grew to comprise several other agents. (Wikipedia)

   

Progabide

4-{[(4-chlorophenyl)[(1E)-3-fluoro-6-oxocyclohexa-2,4-dien-1-ylidene]methyl]amino}butanimidate

C17H16ClFN2O2 (334.0884)


Progabide is an analog and prodrug of gamma-aminobutyric acid. It is commonly used in the treatment of epilepsy. It has agonistic activity for both the GABAA and GABAB receptors. Progabide has been investigated for many diseases besides epilepsy, including Parkinsons disease, schizophrenia, clinical depression and anxiety disorder with varying success. Progabide is a gamma-aminobutyric acid receptor (GABA) agonist.

   

2-Methoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide

2-Methoxy-N-[2-(4-sulphamoylphenyl)ethyl]benzamide

C16H18N2O4S (334.0987)


   

Valine, 3-mercapto-N-((5-oxo-2-(phenylmethyl)-4(5H)-oxazolylidene)methyl)-

2-{[(2-benzyl-5-hydroxy-1,3-oxazol-4-yl)methylidene]amino}-3-methyl-3-sulfanylbutanoic acid

C16H18N2O4S (334.0987)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

Chlorpromazine sulfoxide

2-chloro-10-[3-(dimethylamino)propyl]-10H-5lambda4-phenothiazin-5-one

C17H19ClN2OS (334.0907)


   

Fluorescin

2-(3,6-dihydroxy-9H-xanthen-9-yl)benzoic acid

C20H14O5 (334.0841)


   

2-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)-3-(1H-indol-3-yl)-propionic acid

2-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)-3-(1H-indol-3-yl)propanoic acid

C19H14N2O4 (334.0954)


   

Pentids

6-[(1-Hydroxy-2-phenylethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C16H18N2O4S (334.0987)


   

SCHEMBL4340672

SCHEMBL4340672

C20H14O5 (334.0841)


   

Spiropreussomerin A

Spiropreussomerin A

C20H14O5 (334.0841)


   
   

Palmarumycin JC2

Palmarumycin JC2

C20H14O5 (334.0841)


   

(8R)-8-(3-Furanyl)-4,8-dihydro-7-methyl-3H-furo[3,4:3,4]cyclohept[1,2-f]isobenzofuran-3,10(1H)-dione; Isopuberulin

(8R)-8-(3-Furanyl)-4,8-dihydro-7-methyl-3H-furo[3,4:3,4]cyclohept[1,2-f]isobenzofuran-3,10(1H)-dione; Isopuberulin

C20H14O5 (334.0841)


   
   

Plicadin

9-Hydorxy-6,6-dimethylpyrano[2,3:3,4]coumestan

C20H14O5 (334.0841)


   

8-Ethyl-1,6,11-trihydroxytetracene-5,12-dione

8-Ethyl-1,6,11-trihydroxytetracene-5,12-dione

C20H14O5 (334.0841)


   

Sophoracoumestan A

3-Hydroxy-10,10-dimethyl-6H,10H-furo [ 3,2-c:4,5-g ] bis [ 1 ] benzopyran-6-one

C20H14O5 (334.0841)


   

Maybridge3_006220

Maybridge3_006220

C16H18N2O4S (334.0987)


   

palmarumycin CP3

palmarumycin CP3

C20H14O5 (334.0841)


   

SCHEMBL17867419

SCHEMBL17867419

C20H14O5 (334.0841)


   

cladospirone F

cladospirone F

C20H14O5 (334.0841)


   

Fluorescin

2-(3,6-dihydroxyxanthen-9-yl)benzoic acid

C20H14O5 (334.0841)


   

palmarumycin CP17

palmarumycin CP17

C20H14O5 (334.0841)


   

Daibucarboline B

Daibucarboline B

C19H14N2O4 (334.0954)


A natural product found in Neolitsea daibuensis.

   

CHEMBL564438

CHEMBL564438

C20H14O5 (334.0841)


   

desoxysalvileucantholide|salvileucalin D

desoxysalvileucantholide|salvileucalin D

C20H14O5 (334.0841)


   

(2Z)-2-(4-hydroxybenzylidene)-8-methylfuro[2,3-g] [1]benzoxepine-3,10(2H,7H)-dione|damaurone E

(2Z)-2-(4-hydroxybenzylidene)-8-methylfuro[2,3-g] [1]benzoxepine-3,10(2H,7H)-dione|damaurone E

C20H14O5 (334.0841)


   

salvileucalin C

salvileucalin C

C20H14O5 (334.0841)


   

4(S)-hydroxy-2,3-dihydro-2H-spiro[naphthalene-1(4H),2-naphtho[1,8-de][1,3]dioxin]-5,8-dione|palmarumycin CP18

4(S)-hydroxy-2,3-dihydro-2H-spiro[naphthalene-1(4H),2-naphtho[1,8-de][1,3]dioxin]-5,8-dione|palmarumycin CP18

C20H14O5 (334.0841)


   

(8R)-8-(furan-3-yl)-6,8-dihydro-7-methyl-3H-furo[3,4:3,4]cyclohepta[1,2-f][2]benzofuran-3,10(1H)-dione|dugesin B

(8R)-8-(furan-3-yl)-6,8-dihydro-7-methyl-3H-furo[3,4:3,4]cyclohepta[1,2-f][2]benzofuran-3,10(1H)-dione|dugesin B

C20H14O5 (334.0841)


   
   

4,5-Dehydroisopsoralidin

6-hydroxy-17,17-dimethyl-3,12,16-trioxapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(13),2(10),4(9),5,7,14,18,20-octaen-11-one

C20H14O5 (334.0841)


   

Penicillin G

Penicillin-G

C16H18N2O4S (334.0987)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CE - Beta-lactamase sensitive penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Progabide

Progabide

C17H16ClFN2O2 (334.0884)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AG - Fatty acid derivatives D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018755 - GABA Agonists C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants Progabide is a gamma-aminobutyric acid receptor (GABA) agonist.

   

Benzylpenicillin

Benzylpenicillin

C16H18N2O4S (334.0987)


A penicillin in which the substituent at position 6 of the penam ring is a phenylacetamido group. Origin: Microbe; SubCategory_DNP: beta-Lactams, Penicillins

   

diflufenzopyr

diflufenzopyr

C15H12F2N4O3 (334.0877)


CONFIDENCE standard compound; INTERNAL_ID 1038; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4268; ORIGINAL_PRECURSOR_SCAN_NO 4265 CONFIDENCE standard compound; INTERNAL_ID 1038; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4282; ORIGINAL_PRECURSOR_SCAN_NO 4280 CONFIDENCE standard compound; INTERNAL_ID 1038; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4253; ORIGINAL_PRECURSOR_SCAN_NO 4249 CONFIDENCE standard compound; INTERNAL_ID 1038; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4267; ORIGINAL_PRECURSOR_SCAN_NO 4264 CONFIDENCE standard compound; INTERNAL_ID 1038; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4297; ORIGINAL_PRECURSOR_SCAN_NO 4294 CONFIDENCE standard compound; INTERNAL_ID 1038; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4294; ORIGINAL_PRECURSOR_SCAN_NO 4292 CONFIDENCE standard compound; INTERNAL_ID 1038; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8586; ORIGINAL_PRECURSOR_SCAN_NO 8584 CONFIDENCE standard compound; INTERNAL_ID 1038; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8595; ORIGINAL_PRECURSOR_SCAN_NO 8591 CONFIDENCE standard compound; INTERNAL_ID 1038; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8618; ORIGINAL_PRECURSOR_SCAN_NO 8614 CONFIDENCE standard compound; INTERNAL_ID 1038; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8648; ORIGINAL_PRECURSOR_SCAN_NO 8644 CONFIDENCE standard compound; INTERNAL_ID 1038; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8673; ORIGINAL_PRECURSOR_SCAN_NO 8670 CONFIDENCE standard compound; INTERNAL_ID 1038; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8633; ORIGINAL_PRECURSOR_SCAN_NO 8630

   

Penicillin G; LC-tDDA; CE10

Penicillin G; LC-tDDA; CE10

C16H18N2O4S (334.0987)


   

Penicillin G; LC-tDDA; CE20

Penicillin G; LC-tDDA; CE20

C16H18N2O4S (334.0987)


   

Penicillin G; LC-tDDA; CE30

Penicillin G; LC-tDDA; CE30

C16H18N2O4S (334.0987)


   

Penicillin G; LC-tDDA; CE40

Penicillin G; LC-tDDA; CE40

C16H18N2O4S (334.0987)


   

Penicillin G; AIF; CE0; CorrDec

Penicillin G; AIF; CE0; CorrDec

C16H18N2O4S (334.0987)


   

Penicillin G; AIF; CE10; CorrDec

Penicillin G; AIF; CE10; CorrDec

C16H18N2O4S (334.0987)


   

Penicillin G; AIF; CE30; CorrDec

Penicillin G; AIF; CE30; CorrDec

C16H18N2O4S (334.0987)


   

Penicillin G; AIF; CE0; MS2Dec

Penicillin G; AIF; CE0; MS2Dec

C16H18N2O4S (334.0987)


   

Penicillin G; AIF; CE10; MS2Dec

Penicillin G; AIF; CE10; MS2Dec

C16H18N2O4S (334.0987)


   

Penicillin G; AIF; CE30; MS2Dec

Penicillin G; AIF; CE30; MS2Dec

C16H18N2O4S (334.0987)


   

Oxychlorpromazine

Chlorpromazine sulphoxide

C17H19ClN2OS (334.0907)


   

7-Hydroxychlorpromazine

7-Hydroxychlorpromazine

C17H19ClN2OS (334.0907)


   

RG-108

-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-(S)-1H-indole-3-propanoic acid

C19H14N2O4 (334.0954)


   

His-Gly-OH

2-(3-(2-(1H-imidazol-4-yl)ethoxy)-4-nitrobenzamido)acetic acid

C14H14N4O6 (334.0913)


   

Ala-His-OH

(S)-4-(1H-imidazol-4-yl)-2-(3-methoxy-4-nitrobenzamido)butanoic acid

C14H14N4O6 (334.0913)


   

(S)-a-Amino-2,5-dihydro-5-oxo-4-isoxazolepropanoic acid N2-glucoside

2-amino-3-{5-oxo-2-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2,5-dihydro-1,2-oxazol-4-yl}propanoic acid

C12H18N2O9 (334.1012)


   
   

Triflubazam

Triflubazam

C17H13F3N2O2 (334.0929)


C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

Pyrimido[4,5-g]quinazoline-4,9-dione,3,8-dihydro-5,10-dihydroxy-2,7-bis(hydroxymethyl)-3,8-dimethyl-

Pyrimido[4,5-g]quinazoline-4,9-dione,3,8-dihydro-5,10-dihydroxy-2,7-bis(hydroxymethyl)-3,8-dimethyl-

C14H14N4O6 (334.0913)


   

N-(2-PHENOXYETHYL)-2-PROPANAMINE

N-(2-PHENOXYETHYL)-2-PROPANAMINE

C16H18N2O4S (334.0987)


   

8-anilinonaphthalene-1-sulfonic acid,azane,hydrate

8-anilinonaphthalene-1-sulfonic acid,azane,hydrate

C16H18N2O4S (334.0987)


   

4,4,5,5-TETRAMETHYL-2-(3-TRIFLUOROMETHYLSULFANYLMETHOXY-PHENYL)-[1,3,2]DIOXABOROLANE

4,4,5,5-TETRAMETHYL-2-(3-TRIFLUOROMETHYLSULFANYLMETHOXY-PHENYL)-[1,3,2]DIOXABOROLANE

C14H18BF3O3S (334.1022)


   

Triphenoxy(vinyl)silane

Triphenoxy(vinyl)silane

C20H18O3Si (334.1025)


   

Phenazine ethosulfate

5-Ethylphenazin-5-ium ethyl sulfate

C16H18N2O4S (334.0987)


   

2-tritylsulfanylacetic acid

2-tritylsulfanylacetic acid

C21H18O2S (334.1027)


   

3,3-(Hexafluoroisopropylidene)dianiline

3,3-(Hexafluoroisopropylidene)dianiline

C15H12F6N2 (334.0905)


   

1,5-DIPHENYL-3-(4-CHLOROPHENYL)FORMAZAN

1,5-DIPHENYL-3-(4-CHLOROPHENYL)FORMAZAN

C19H15ClN4 (334.0985)


   

2,2-Bis(4-aminophenyl)hexafluoropropane

2,2-Bis(4-aminophenyl)hexafluoropropane

C15H12F6N2 (334.0905)


   

ETHYL 2-(1-(((BENZYLOXY)CARBONYL)AMINO)ETHYL)THIAZOLE-5-CARBOXYLATE

ETHYL 2-(1-(((BENZYLOXY)CARBONYL)AMINO)ETHYL)THIAZOLE-5-CARBOXYLATE

C16H18N2O4S (334.0987)


   

[cyclohexylsulfonyl(diazo)methyl]sulfonylcyclohexane

[cyclohexylsulfonyl(diazo)methyl]sulfonylcyclohexane

C13H22N2O4S2 (334.1021)


   

2,3,4-Tri-O-acetyl-D-glucuronide methyl ester

2,3,4-Tri-O-acetyl-D-glucuronide methyl ester

C13H18O10 (334.09)


   

benzyl 2-(4-methylphenyl)sulfonyloxypropanoate

benzyl 2-(4-methylphenyl)sulfonyloxypropanoate

C17H18O5S (334.0875)


   

Febuxostat impurity 7

Febuxostat impurity 7

C16H18N2O4S (334.0987)


   

INDIUM(III) TERT-BUTOXIDE

INDIUM(III) TERT-BUTOXIDE

C12H27InO3 (334.0999)


   

5-hydroxy-[1,1:3,1-terphenyl]-4,4-dicarboxylic acid

5-hydroxy-[1,1:3,1-terphenyl]-4,4-dicarboxylic acid

C20H14O5 (334.0841)


   

Febuxostat amide impurity

Febuxostat amide impurity

C16H18N2O4S (334.0987)


   

4,4-diamino-2,2-di-(trifluoromethyl)-diphenylmethane

4,4-diamino-2,2-di-(trifluoromethyl)-diphenylmethane

C15H12F6N2 (334.0905)


   

4-(1-Allyl-7-(trifluoromethyl)-1H-indazol-3-yl)benzene-1,3-diol

4-(1-Allyl-7-(trifluoromethyl)-1H-indazol-3-yl)benzene-1,3-diol

C17H13F3N2O2 (334.0929)


   

Mefuparib hydrochloride

Mefuparib hydrochloride

C17H16ClFN2O2 (334.0884)


   

2,3,4-Tri-O-acetyl-alpha-D-glucuronic Acid Methyl Ester

2,3,4-Tri-O-acetyl-alpha-D-glucuronic Acid Methyl Ester

C13H18O10 (334.09)


   

2-[(3-Methoxyphenyl)-oxomethyl]imino-3,4-dimethyl-5-thiazolecarboxylic acid ethyl ester

2-[(3-Methoxyphenyl)-oxomethyl]imino-3,4-dimethyl-5-thiazolecarboxylic acid ethyl ester

C16H18N2O4S (334.0987)


   

Salvileucalin B

Salvileucalin B

C20H14O5 (334.0841)


A diterpenoid with a rearranged neo-clerodane skeleton isolated from Salvia leucantha and has been shown exhibit antineoplastic activity.

   

8-Hydroxychlorpromazine

8-Hydroxychlorpromazine

C17H19ClN2OS (334.0907)


   

Phenothiazine, 2-chloro-10-(3-(dimethylamino)propyl)-3-hydroxy-

Phenothiazine, 2-chloro-10-(3-(dimethylamino)propyl)-3-hydroxy-

C17H19ClN2OS (334.0907)


   

N-Pyridoxyl-2-methylalanine-5-phosphate

N-Pyridoxyl-2-methylalanine-5-phosphate

C12H19N2O7P (334.093)


   

(5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

(5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C16H18N2O4S (334.0987)


   

2,3,5-Triphenyltetrazolium chloride

2,3,5-Triphenyltetrazolium chloride

C19H15ClN4 (334.0985)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D013778 - Tetrazolium Salts D004396 - Coloring Agents

   

3-Epi-3-hydroxymugineate(2-)

3-Epi-3-hydroxymugineate(2-)

C12H18N2O9-2 (334.1012)


   

gamma-L-glutamyl-(S)-2-carboxypropyl-L-cysteine

gamma-L-glutamyl-(S)-2-carboxypropyl-L-cysteine

C12H18N2O7S-2 (334.0835)


   

RG108

N-Phthalyl-L-Tryptophan

C19H14N2O4 (334.0954)


   
   

2-(2-ethylphenoxy)-N-(4-sulfamoylphenyl)acetamide

2-(2-ethylphenoxy)-N-(4-sulfamoylphenyl)acetamide

C16H18N2O4S (334.0987)


   

N-[(2-benzyl-5-oxo-1,3-oxazol-4(5H)-ylidene)methyl]-3-sulfanyl-D-valine

N-[(2-benzyl-5-oxo-1,3-oxazol-4(5H)-ylidene)methyl]-3-sulfanyl-D-valine

C16H18N2O4S (334.0987)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

N-[3-[methyl(methylsulfonyl)amino]phenyl]-2-phenoxyacetamide

N-[3-[methyl(methylsulfonyl)amino]phenyl]-2-phenoxyacetamide

C16H18N2O4S (334.0987)


   

5-[(5-acetyl-2-propan-2-yloxyphenyl)methyl]-6-hydroxy-2-sulfanylidene-1H-pyrimidin-4-one

5-[(5-acetyl-2-propan-2-yloxyphenyl)methyl]-6-hydroxy-2-sulfanylidene-1H-pyrimidin-4-one

C16H18N2O4S (334.0987)


   

2-[3-Phenyl-7-(trifluoromethyl)-1-indazolyl]acetic acid methyl ester

2-[3-Phenyl-7-(trifluoromethyl)-1-indazolyl]acetic acid methyl ester

C17H13F3N2O2 (334.0929)


   

4-(4-{[(4-Aminophenyl)sulfonyl]amino}phenyl)butanoic acid

4-(4-{[(4-Aminophenyl)sulfonyl]amino}phenyl)butanoic acid

C16H18N2O4S (334.0987)


   

3-(2-chloro-10-oxido-10-phenothiazin-10-iumyl)-N,N-dimethyl-1-propanamine

3-(2-chloro-10-oxido-10-phenothiazin-10-iumyl)-N,N-dimethyl-1-propanamine

C17H19ClN2OS (334.0907)


   

(2S,5S,6R)-3,3-dimethyl-7-oxo-6-[(1-oxo-2-phenylethyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

(2S,5S,6R)-3,3-dimethyl-7-oxo-6-[(1-oxo-2-phenylethyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C16H18N2O4S (334.0987)


   

Chlorpromazine N-oxide

Chlorpromazine N-oxide

C17H19ClN2OS (334.0907)


An organochlorine compound that is chlorpromazine in which the acyclic tertiary amino group has been converted into the corresponding N-oxide.

   

Benzylpenicillenic acid

Benzylpenicillenic acid

C16H18N2O4S (334.0987)


A penicillenic acid having a benzyl substituent at the 2-position on the oxazolone ring.

   

Hydroxy-O-methyltetrangulol

Hydroxy-O-methyltetrangulol

C20H14O5 (334.0841)


   

1,4,8,9-tetrahydroxy-1h,2h,12ch-benzo[j]fluoranthen-3-one

1,4,8,9-tetrahydroxy-1h,2h,12ch-benzo[j]fluoranthen-3-one

C20H14O5 (334.0841)


   

2,7b-dihydro-1ah-2',4'-dioxaspiro[naphtho[1,2-b]oxirene-3,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2,7-diol

2,7b-dihydro-1ah-2',4'-dioxaspiro[naphtho[1,2-b]oxirene-3,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-2,7-diol

C20H14O5 (334.0841)


   

(13r)-13-(furan-3-yl)-11-methyl-4,14-dioxatetracyclo[8.7.0.0²,⁶.0¹²,¹⁶]heptadeca-1(17),2(6),8,10,12(16)-pentaene-5,15-dione

(13r)-13-(furan-3-yl)-11-methyl-4,14-dioxatetracyclo[8.7.0.0²,⁶.0¹²,¹⁶]heptadeca-1(17),2(6),8,10,12(16)-pentaene-5,15-dione

C20H14O5 (334.0841)


   

(1s,4s,8r,9s)-2',4',11-trioxaspiro[tricyclo[6.2.1.0⁴,⁹]undecane-10,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',6,7',9',11'-hexaene-3,5-dione

(1s,4s,8r,9s)-2',4',11-trioxaspiro[tricyclo[6.2.1.0⁴,⁹]undecane-10,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',6,7',9',11'-hexaene-3,5-dione

C20H14O5 (334.0841)


   

4-hydroxy-3,4-dihydro-2h-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-5,8-dione

4-hydroxy-3,4-dihydro-2h-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-5,8-dione

C20H14O5 (334.0841)


   

(2s,5r,6r)-6-[(1-hydroxy-2-phenylethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

(2s,5r,6r)-6-[(1-hydroxy-2-phenylethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C16H18N2O4S (334.0987)


   

13-(furan-3-yl)-11-methyl-4,14-dioxatetracyclo[8.7.0.0²,⁶.0¹²,¹⁶]heptadeca-1(17),2(6),8,10,12(16)-pentaene-5,15-dione

13-(furan-3-yl)-11-methyl-4,14-dioxatetracyclo[8.7.0.0²,⁶.0¹²,¹⁶]heptadeca-1(17),2(6),8,10,12(16)-pentaene-5,15-dione

C20H14O5 (334.0841)


   

palmarumycin cp18

palmarumycin cp18

C20H14O5 (334.0841)


   

7,7a-dihydro-1ah-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-6,7-diol

7,7a-dihydro-1ah-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-6,7-diol

C20H14O5 (334.0841)


   

(13r)-13-(furan-3-yl)-11-methyl-4,14-dioxatetracyclo[8.7.0.0²,⁶.0¹²,¹⁶]heptadeca-1(17),2(6),7,10,12(16)-pentaene-5,15-dione

(13r)-13-(furan-3-yl)-11-methyl-4,14-dioxatetracyclo[8.7.0.0²,⁶.0¹²,¹⁶]heptadeca-1(17),2(6),7,10,12(16)-pentaene-5,15-dione

C20H14O5 (334.0841)


   

(2s)-2,5-dihydroxy-2,3-dihydro-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-4-one

(2s)-2,5-dihydroxy-2,3-dihydro-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-4-one

C20H14O5 (334.0841)


   

(2s,6r)-6-[(1-hydroxy-2-phenylethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

(2s,6r)-6-[(1-hydroxy-2-phenylethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C16H18N2O4S (334.0987)


   

4,6b,9-trihydroxy-1h,2h,7h-benzo[j]fluoranthene-3,8-dione

4,6b,9-trihydroxy-1h,2h,7h-benzo[j]fluoranthene-3,8-dione

C20H14O5 (334.0841)


   

(1as,7r,7as)-7,7a-dihydro-1ah-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-6,7-diol

(1as,7r,7as)-7,7a-dihydro-1ah-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-6,7-diol

C20H14O5 (334.0841)


   

spiropreussione c

spiropreussione c

C20H14O5 (334.0841)


   

2',4',11-trioxaspiro[tricyclo[6.2.1.0⁴,⁹]undecane-10,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',6,7',9',11'-hexaene-3,5-dione

2',4',11-trioxaspiro[tricyclo[6.2.1.0⁴,⁹]undecane-10,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',6,7',9',11'-hexaene-3,5-dione

C20H14O5 (334.0841)


   

7,8-dimethoxy-10-phenyl-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione

7,8-dimethoxy-10-phenyl-3-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),5,7,9,11-pentaene-2,4-dione

C20H14O5 (334.0841)


   

2,5-dihydroxy-2,3-dihydro-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-4-one

2,5-dihydroxy-2,3-dihydro-2',4'-dioxaspiro[naphthalene-1,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaen-4-one

C20H14O5 (334.0841)


   

6-[(1-hydroxy-2-phenylethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

6-[(1-hydroxy-2-phenylethylidene)amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C16H18N2O4S (334.0987)


   

(1s)-5,8-dihydroxy-1-methyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁶,²⁰]icosa-2,4,6,8,10,13(20),15-heptaene-12,17-dione

(1s)-5,8-dihydroxy-1-methyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁶,²⁰]icosa-2,4,6,8,10,13(20),15-heptaene-12,17-dione

C20H14O5 (334.0841)


   

7,7a-dihydro-1ah-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-4,7-diol

7,7a-dihydro-1ah-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-4,7-diol

C20H14O5 (334.0841)


   

(1s,12cr)-1,4,8,9-tetrahydroxy-1h,2h,12ch-benzo[j]fluoranthen-3-one

(1s,12cr)-1,4,8,9-tetrahydroxy-1h,2h,12ch-benzo[j]fluoranthen-3-one

C20H14O5 (334.0841)


   

4-[(1e,3z)-2,4-diisocyanato-4-(4-methoxyphenyl)buta-1,3-dien-1-yl]phenol

4-[(1e,3z)-2,4-diisocyanato-4-(4-methoxyphenyl)buta-1,3-dien-1-yl]phenol

C19H14N2O4 (334.0954)


   

(1s,8r,9s)-2',4',11-trioxaspiro[tricyclo[6.2.1.0⁴,⁹]undecane-10,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',6,7',9',11'-hexaene-3,5-dione

(1s,8r,9s)-2',4',11-trioxaspiro[tricyclo[6.2.1.0⁴,⁹]undecane-10,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',6,7',9',11'-hexaene-3,5-dione

C20H14O5 (334.0841)


   
   

(6bs)-4,6b,9-trihydroxy-1h,2h,7h-benzo[j]fluoranthene-3,8-dione

(6bs)-4,6b,9-trihydroxy-1h,2h,7h-benzo[j]fluoranthene-3,8-dione

C20H14O5 (334.0841)


   

(1ar,7s,7ar)-7,7a-dihydro-1ah-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-6,7-diol

(1ar,7s,7ar)-7,7a-dihydro-1ah-2',4'-dioxaspiro[naphtho[2,3-b]oxirene-2,3'-tricyclo[7.3.1.0⁵,¹³]tridecane]-1'(13'),5',7',9',11'-pentaene-6,7-diol

C20H14O5 (334.0841)


   

13-(furan-3-yl)-11-methyl-4,14-dioxatetracyclo[8.7.0.0²,⁶.0¹²,¹⁶]heptadeca-1(17),2(6),7,10,12(16)-pentaene-5,15-dione

13-(furan-3-yl)-11-methyl-4,14-dioxatetracyclo[8.7.0.0²,⁶.0¹²,¹⁶]heptadeca-1(17),2(6),7,10,12(16)-pentaene-5,15-dione

C20H14O5 (334.0841)